MedTrace Logo

Assessment of the Efficacy of FOSFOMYCIN in Patients With Bacterial Infection

NCT01173575 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 209

Last updated 2019-07-02

No results posted yet for this study

Summary

This project aims to assess the clinical and microbiological efficacy of fosfomycin(FOM) in patients with bacterial infection.

Primary objective:

• To assess clinical and microbiological efficacy of FOM in patients with bacterial infection.

Secondary objectives:

* To determine the rate and severity of unexpected adverse events.
* To determine the mean duration of therapy with FOM in patients with bacterial infection.

Study design:

Multi-center, non-interventional study

Conditions

Sponsors & Collaborators

  • J&P Medical Research Ltd.

    collaborator OTHER

  • Sandoz GmbH

    collaborator INDUSTRY

  • Infectopharm Arzneimittel GmbH

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Austria
  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01173575 on ClinicalTrials.gov